← Leaderboards
Alice Chen Fan
Stanford University
$2,474,246
Attributed
$2,971,520
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $394K · FY2010–25$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,971,520 · 6
By mechanism
R21$992,538 · 3
U54$954,042 · 1
K23$867,240 · 1
R03$157,700 · 1
Top collaborators
- Jeremy Dahl2 shared
- Aya Kamaya2 shared
- Shan X. Wang2 shared
Most similar at Stanford University
Same institution · by research overlap
- Shan X. Wang$16,205,138
- Utkan Demirci$14,678,583
- Edward S. Boyden$43,934,074
- Bruce L Daniel$13,717,379
- Sandy A Napel$7,568,725
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseTumorMalignant NeoplasmsBloodMolecularMonitorProtocols DocumentationSignal TransductionTechnologySamplingMeasurementBaseResearch PersonnelAntibodiesPharmaceutical PreparationsSpecimenPilot ProjectsClinical TrialsNew TechnologyInstitutesCancer CenterFundingCancer TherapyProteins
Grant awards (16)
Exosome Signatures of Kidney Cancer Response to Immune Checkpoint Inhibitor$215,985
R21 · FY2025 · CA · contact PI
Serial Ultrasound to Detect Early Response to Immunotherapy in Metastatic RCC$212,197
R21 · FY2023 · CA · contact PI
Serial Ultrasound to Detect Early Response to Immunotherapy in Metastatic RCC$180,888
R21 · FY2022 · CA · contact PI
Early therapeutic monitoring of response to therapy with serial ultrasound in metastatic RCC$157,700
R03 · FY2020 · CA · contact PI
Clinical Translational Core$181,881
U54 · FY2019 · CA · contact PI
Clinical Translational Core$187,547
U54 · FY2018 · CA · contact PI
Clinical Translational Core$202,367
U54 · FY2017 · CA · contact PI
Clinical Translational Core$197,150
U54 · FY2016 · CA · contact PI
Analysis of CTCs for Early Prediction of Response to Treatment in RCC$174,544
R21 · FY2016 · CA
Analysis of CTCs for Early Prediction of Response to Treatment in RCC$208,924
R21 · FY2015 · CA
Clinical Translational Core$185,097
U54 · FY2015 · CA · contact PI
Nanoscale analysis of proteomic response to novel targeted therapies for lymphoma$173,448
K23 · FY2014 · CA · contact PI
Nanoscale analysis of proteomic response to novel targeted therapies for lymphoma$173,448
K23 · FY2013 · CA · contact PI
Nanoscale analysis of proteomic response to novel targeted therapies for lymphoma$173,448
K23 · FY2012 · CA · contact PI
Nanoscale analysis of proteomic response to novel targeted therapies for lymphoma$173,448
K23 · FY2011 · CA · contact PI
Nanoscale analysis of proteomic response to novel targeted therapies for lymphoma$173,448
K23 · FY2010 · CA · contact PI